Trial Profile
Effect of INtervention with DMR, GLP-1 and lifestyle intensification -in Subjects with insulin dePendent type 2 diabetes- on Insulin Requirement and mEtabolic parameters Effect
Status:
Completed
Phase of Trial:
Phase III/IV
Latest Information Update: 22 Mar 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INSPIRE
- 21 Mar 2021 Status changed from recruiting to completed.
- 15 Sep 2017 New trial record